Pentz, Rowan D

$105,000.00 CAD

≈ 16 months of average Canadian pay
Department
Canadian Institutes of Health Research
Program
Recipient country
Canada
Fiscal year
2017-2018
Agreement period
May 1, 2017 – April 30, 2020
Reference
cihr-irsc:236-2017-2018-Q1-00578

Published purpose

Immunotherapy against neuroserpin to correct Nerve Growth Factor metabolic dysfunction and consequent cholinergic and cognitive deficits in a transgenic rat model of Alzheimer's disease.

Community tags

Tags are applied by readers, not by this site. One tag per person per record.

Good value Local impact Needs context Questionable Success story Wasteful
View official source record Imported July 30, 2026 from open.canada.ca Grants & Contributions